Advertisement
EXFY vs ONMD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EXFY is a Hold and ONMD is a Hold.
EXFY's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for EXFY turned positive on October 09, 2026. Looking at past instances where EXFY's MACD turned positive, the stock continued to rise in 33 of 39 cases over the following month. The odds of a continued upward trend are 85%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on EXFY as a result. In 62 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.
EXFY moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.48% 3-day Advance, the price is estimated to grow further. Considering data from situations where EXFY advanced for three days, in 165 of 225 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
The Aroon Indicator entered an Uptrend today. In 98 of 136 cases where EXFY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 72%.
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 10-day moving average for EXFY crossed bearishly below the 50-day moving average on October 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EXFY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. EXFY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.457) is normal, around the industry mean (51.922). P/E Ratio (103.093) is within average values for comparable stocks, (82.636). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.135). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (1.573) is also within normal values, averaging (70.810).
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EXFY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
ONMD in upward trend: price expected to rise as it breaks its lower Bollinger Band on September 29, 2026
ONMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 18 of 21 cases where ONMD's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 86%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ONMD's RSI Indicator exited the oversold zone, 15 of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 35 of 58 cases where ONMD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 60%.
Following a +18.75% 3-day Advance, the price is estimated to grow further. Considering data from situations where ONMD advanced for three days, in 113 of 149 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 25, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ONMD as a result. In 48 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 59%.
The Moving Average Convergence Divergence Histogram (MACD) for ONMD turned negative on September 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 58 similar instances when the indicator turned negative. In 31 of the 58 cases the stock turned lower in the days that followed. This puts the odds of success at 53%.
ONMD moved below its 50-day moving average on September 25, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ONMD crossed bearishly below the 50-day moving average on September 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ONMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for ONMD entered a downward trend on September 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (7.432). P/E Ratio (38.927) is within average values for comparable stocks, (46.656). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. ONMD's P/S Ratio (23.529) is slightly higher than the industry average of (6.065).
The Tickeron Price Growth Rating for this company is 90 (best 1 - 100 worst), indicating slightly worse than average price growth. ONMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ONMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.
| EXFY | ONMD | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 79% |
| Stochastic ODDS (%) | 2 days ago 85% | 2 days ago 60% |
| Momentum ODDS (%) | 2 days ago 71% | 2 days ago 59% |
| MACD ODDS (%) | 2 days ago 85% | 2 days ago 53% |
| TrendWeek ODDS (%) | 2 days ago 77% | 2 days ago 76% |
| TrendMonth ODDS (%) | 2 days ago 74% | 2 days ago 86% |
| Advances ODDS (%) | 2 days ago 73% | 2 days ago 76% |
| Declines ODDS (%) | 19 days ago 88% | 5 days ago 90% |
| BollingerBands ODDS (%) | N/A | 2 days ago 86% |
| Aroon ODDS (%) | 2 days ago 72% | 4 days ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EXFY’s FA Score shows that 0 FA rating(s) are green while ONMD’s FA Score has 1 green FA rating(s).
- EXFY’s FA Score: 0 green, 5 red.
- ONMD’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EXFY’s TA Score shows that 5 TA indicator(s) are bullish while ONMD’s TA Score has 4 bullish TA indicator(s).
- EXFY’s TA Score: 5 bullish, 3 bearish.
- ONMD’s TA Score: 4 bullish, 6 bearish.
Price Growth
EXFY (@Packaged Software) experienced а +9.78% price change this week, while ONMD (@Services to the Health Industry) price change was -1.45% for the same time period.
The average weekly price growth across all stocks in the @Packaged Software industry was -5.63%. For the same industry, the average monthly price growth was -6.15%, and the average quarterly price growth was -1.98%.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was -4.20%. For the same industry, the average monthly price growth was -4.08%, and the average quarterly price growth was +10.25%.
Reported Earning Dates
EXFY is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Packaged Software (-5.63% weekly)Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.
@Services to the Health Industry (-4.20% weekly)This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| KRE | 69.75 | 1.21 | +1.77% |
| State Street SPDR S&P Regional Banking ETF (KRE) | |||
| AAEQ | 55.31 | 0.13 | +0.23% |
| Alpha Architect US Equity 2 ETF (AAEQ) | |||
| MYCG | 24.89 | 0.02 | +0.06% |
| State Street My2027 Corporate Bond ETF (MYCG) | |||
| QBKV | 26.77 | N/A | N/A |
| AllianzIM U.S. Small Cap Buffer5 ETF (QBKV) | |||
| TRPA | 38.99 | -0.07 | -0.18% |
| Hartford AAA CLO ETF (TRPA) | |||
EXFY and
Correlation & Price change
A.I.dvisor indicates that over the last year, EXFY has been loosely correlated with CLSK. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if EXFY jumps, then CLSK could also see price increases.
| Ticker / NAME | Correlation To EXFY | 1D Price Change % | ||
|---|---|---|---|---|
| EXFY | 100% | +3.06% | ||
| CLSK - EXFY | 53% Loosely correlated | +1.36% | ||
| COIN - EXFY | 47% Loosely correlated | +6.32% | ||
| RIOT - EXFY | 46% Loosely correlated | +2.65% | ||
| DOCS - EXFY | 44% Loosely correlated | +5.28% | ||
| HOOD - EXFY | 44% Loosely correlated | +2.88% | ||
More | ||||
ONMD and
Correlation & Price change
A.I.dvisor tells us that ONMD and EVCM have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ONMD and EVCM's prices will move in lockstep.
| Ticker / NAME | Correlation To ONMD | 1D Price Change % | ||
|---|---|---|---|---|
| ONMD | 100% | +0.85% | ||
| EVCM - ONMD | 24% Poorly correlated | +1.71% | ||
| HUCK - ONMD | 24% Poorly correlated | +5.25% | ||
| EXFY - ONMD | 23% Poorly correlated | +3.06% | ||
| PLTK - ONMD | 22% Poorly correlated | +6.34% | ||
| PRTH - ONMD | 22% Poorly correlated | N/A | ||
More | ||||